Results 251 to 260 of about 29,663 (265)

Immunological considerations for COVID-19 vaccine strategies

Nature Reviews Immunology, 2020
Fiona Smaill, Matthew S Miller, Brian Dennis Lichty   +2 more
exaly  

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

Nature, 2020
Kizzmekia S Corbett, Darin K Edwards, Sarah R Leist   +2 more
exaly  

Pityriasis lichenoides chronic after measles–mumps–rubella vaccination

The Journal of Dermatology, 2011
Deborah GIL‐BISTES, Nicolas KLUGER, Didier BESSIS, Bernard GUILLOT, Nadia RAISON‐PEYRON   +4 more
openaire   +1 more source

Viruses as vaccine vectors for infectious diseases and cancer

Nature Reviews Microbiology, 2009
Simon J. Draper
exaly  

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

Nature, 2020
Ugur Sahin, Petra Oehm, Mathias Vormehr
exaly  

Group B Streptococcus: global incidence and vaccine development

Nature Reviews Microbiology, 2006
Atul Kumar Johri, Philippe Glaser, Guido Grandi   +2 more
exaly  

Measles-Mumps-Rubella Vaccine in the Italian Armed Forces

JAMA: The Journal of the American Medical Association, 2000
D'AMELIO, Raffaele, BISELLI R, FASCIA G, NATALICCHIO S.   +3 more
openaire   +2 more sources

Measles + Mumps + Rubella Vaccine (MMR Vaccine)

2018
openaire   +1 more source

Measles + Mumps + Rubella + Varicella Vaccine

2018
openaire   +1 more source

Declines in human papillomavirus infection observed in the vaccine era

Ca-A Cancer Journal for Clinicians, 2013
exaly